Concepedia

Judit Kralovánszky

JK

Statistics

Publications

19

Citations

514

H-Index

16

Active since

1969

Affiliations

National Institute of Oncology(Current)

Semmelweis University

Eötvös Loránd University

Judit Kralovánszky is an author at National Institute of Oncology specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1969–2011

19

Publications

19

Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil

Erika Hitre, Barna Budai, Vilmos Adleff et al. · Pharmacogenetics and Genomics · 2005 · 69 citations

, , +12

Putative Role of Dihydropyrimidine Dehydrogenase in the Toxic Side Effect of 5-Fluorouracil in Colorectal Cancer Patients

Csilla Katona, Judit Kralovánszky, András Rosta et al. · Oncology · 1998 · 52 citations

SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer

Viktor Komlósi, Erika Hitre, Éva Pap et al. · BMC Cancer · 2010 · 48 citations · Full text

Heterozygote deficiency in thymidylate synthase enhancer region polymorphism genotype distribution in Hungarian colorectal cancer patients

Vilmos Adleff, Erika Hitre, István Köves et al. · International Journal of Cancer · 2004 · 36 citations · Full text

The Association of Polymorphisms in 5-Fluorouracil Metabolism Genes with Outcome in Adjuvant Treatment of Colorectal Cancer

Shoaib Afzal, Milena Gusella, S⊘ren Astrup Jensen et al. · Pharmacogenomics · 2011 · 32 citations

1–5 of 19